암치료를 위한 네트워크 기반 접근방식 활용 시스템 수준 연구 = Investigating herbal active ingredients and systems-level mechanisms on the human cancers

다국어 초록 (Multilingual Abstract)

Objective : This study aims to investigate the active ingredients and potential mechanisms of the beneficial herb on human cancers such as the liver by employing network pharmacology. Methods : Ingredients and their target information was obtained from various databases such as TM-MC, TTD, and Drugbank. Related protein for liver cancer was retrieved from the Comparative Toxicogenomics Database and literature. A hypergeometric test and gene set enrichment analysis were conducted to evaluate associations between protein targets of red ginseng (Panax ginseng C. A. Meyer) and liver cancer-related proteins and identify related signaling pathways, respectively. Network proximity was employed to identify active ingredients of red ginseng on liver cancer. Results : A compound-target network of red ginseng was constructed, which consisted of 363 edges between 53 ingredients and 121 protein targets. MAPK signaling pathway, PI3K-Akt signaling pathway, p53 signaling pathway, TGF-beta signaling pathway, and cell cycle pathway was significantly associated with protein targets of red ginseng. Network proximity results indicated that Ginsenoside Rg1, Acetic Acid, Ginsenoside Rh2, 20(R)-Ginsenoside Rg3, Notoginsenoside R1, Ginsenoside Rk1, 2-Methylfuran, Hexanal, Ginsenoside Rd, Ginsenoside Rh1 could be active ingredients of red ginseng against liver cancer. Conclusion : This study suggests that network-based approaches could be useful to explore potential mechanisms and active ingredients of red ginseng for liver cancer.

참고문헌 (Reference)

1 남기열 ; 이누리 ; 문병두 ; 송규용 ; 신호상 ; 최재을, "흑삼 제조과정 중 증포 횟수에 따른 색상 및 진세노사이드 함량 변화" 한국약용작물학회 20 (20): 27-35, 2012

2 Zhu F, "Update of TTD : Therapeutic Target Database" 38 : D787-D791, 2009

3 Lee WY, "The methodological trends of traditional herbal medicine employing network pharmacology" 9 (9): 1-15, 2019

4 Gene Ontology Consortium, "The Gene Ontology(GO)database and informatics resource" 32 : D258-D261, 2004

5 Davis AP, "The Comparative Toxicogenomics Database : Update 2019" 47 : D948-D954, 2019

6 Kim SK, "TM-MC : A database of medicinal materials and chemical compounds in Northeast Asian traditional medicine" 15 (15): 1-8, 2015

7 Tian S, "Systems Biology Analysis of the Effect and Mechanism of Qi-Jing-Sheng-Bai Granule on Leucopenia in Mice" 10 : 1-16, 2019

8 Koopmans F, "SynGO : an evidence-based, expert-curated knowledge base for the synapse" 103 (103): 217-234, 2019

9 Szklarczyk D, "STITCH 5 : Augmenting protein-chemical interaction networks with tissue and affinity data" 44 : D380-D384, 2016

10 Shirakami Y, "Retinoid roles in blocking hepatocellular carcinoma" 4 (4): 1-7, 2015

11 Guney E, "Network-based in silico drug efficacy screening" 7 : 1-13, 2016

12 Hopkins AL, "Network pharmacology : The next paradigm in drug discovery" 4 (4): 682-690, 2008

13 Ogata H, "KEGG : Kyoto encyclopedia of genes and genomes" 27 (27): 29-34, 1999

14 Li Y, "In vitro anti-hepatoma activities of notoginsenoside R1through downregulation of tumor promoter miR-21" 65 (65): 1364-1375, 2020

15 Lee WY, "Identifying candidate flavonoids for non-alcoholic fatty liver disease by network-based strategy" 13 (13): 1-14, 2022

16 Mancuso A, "Hepatocellular carcinoma and liver transplantation : state of the art" 2 (2): 176-181, 2014

17 Gao Y, "Hepataprotective effects of ginsenoside Rg1–A review" 206 : 178-183, 2017

18 Yang Z, "Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy" 6 (6): 1-13, 2016

19 Subramanian A, "Gene set enrichment analysis : A knowledge-based approach for interpreting genome-wide expression profiles" 102 (102): 15545-15550, 2005

20 오지선 ; Seong Bin Jeon ; 이유리 ; 이혜지 ; 김주 ; 권보라 ; 유강열 ; 차정단 ; 황승미 ; 최경민 ; 정용섭, "Fermented Red Ginseng Extract Inhibits Cancer Cell Proliferation and Viability" 한국식품영양과학회 18 (18): 421-428, 2015

21 Shannon P, "Cytoscape : a software environment for integrated models of biomolecular interaction networks" 13 (13): 2498-2504, 2003

22 Kim YJ, "Anti-tumor activity of the ginsenoside Rk1 in human hepatocellular carcinoma cells through inhibition of telomerase activity and induction of apoptosis" 31 (31): 826-830, 2008

23 Huang Y, "A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling" 26 : 1143-1158.e6, 2019

24 Zhu GY, "20 (S)-Protopanaxadiol, a metabolite of ginsenosides, induced cell apoptosis through endoplasm ic reticulum stress in hum an hepatocarcinom a HepG2 cells" 668 (668): 88-98, 2011